PronoKal Foundation Report issue

Foundation Phase 1 Phase 4

Organization Overview

First Clinical Trial
2013
NCT01865448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pronokal group | Protein Supplies SL